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Abstract 1	
The bacterial type VI secretion system (T6SS) delivers effectors into eukaryotic host 2	
cells or toxins into bacterial competitor for survival and fitness. The T6SS is positively 3	
regulated by the threonine phosphorylation pathway (TPP) and negatively by the 4	
T6SS-accessory protein TagF.	Here, we studied the mechanisms underlying TagF-mediated 5	
T6SS repression in two distinct bacterial pathogens, Agrobacterium tumefaciens and 6	
Pseudomonas aeruginosa. We found that in A. tumefaciens, T6SS toxin secretion and 7	
T6SS-dependent antibacterial activity are suppressed by a two-domain chimeric protein 8	
consisting of TagF and PppA, a putative phosphatase. Remarkably, this TagF domain is 9	
sufficient to post-translationally repress the T6SS, and this inhibition is independent of TPP. 10	
This repression requires interaction with a cytoplasmic protein, Fha,	 critical for activating 11	
T6SS assembly. In P. aeruginosa, PppA and TagF are two distinct proteins that repress T6SS 12	
in a TPP-dependent and -independent pathways, respectively. P. aeruginosa TagF interacts 13	
with Fha1, suggesting that formation of this complex represents a conserved TagF-mediated 14	
regulatory mechanism. Using TagF variants with substitutions of conserved amino acid 15	
residues at predicted protein–protein interaction interfaces, we uncovered evidence that the 16	
TagF–Fha interaction is critical for TagF-mediated T6SS repression in both bacteria. TagF 17	
inhibits T6SS without affecting T6SS protein abundance in A. tumefaciens, but TagF 18	
overexpression reduces the protein levels of all analyzed T6SS components in P. aeruginosa. 19	
Our results indicate that TagF interacts with Fha, which in turn could impact different stages 20	
of T6SS assembly in different bacteria, possibly reflecting an evolutionary divergence in 21	
T6SS control. 22	
	  23	
	 3	
 1	
Introduction 2	
The type VI secretion system (T6SS) is a versatile weapon deployed by many bacterial 3	
species to deliver diverse effector proteins into eukaryotic host cells or bacterial competitors. 4	
The major target of T6SS antibacterial effectors include the membrane-, cell wall-, or nucleic 5	
acid, some of these are shared by eukaryote-targeting effectors, e.g. membranes, while the 6	
latter may have additional targets, e.g. actin cytoskeleton. The delivery and activity of these 7	
T6SS toxins and effectors have a clear impact in interbacterial competition and/or 8	
pathogenesis during eukaryotic host infection (1,2). The T6SS apparatus relies on 9	
approximately 13-14 conserved core components to build a contractile phage tail-like 10	
structure anchored to the bacterial cell envelope. To initiate the T6SS assembly, a TssJLM (or 11	
TssLM) trans-membrane complex (3-6) serves as a docking site for the TssAEFGK baseplate 12	
complex (7, 8), with TssK bridging the baseplate and the membrane complex. On the 13	
baseplate, Hcp is polymerized in a tail tube-like structure and wrapped around by a TssB–14	
TssC outer sheath. In some studies it was proposed that TssA is responsible for initiating 15	
sheath polymerization (9). Upon contraction of the sheath, the Hcp tube tipped by the 16	
VgrG-PAAR puncturing device and the T6SS effectors associated with it (10,11) are 17	
propelled across the cell envelope. 18	
 T6SS is regulated at multiple levels (12-15). A subset of T6SS gene clusters encode 19	
orthologs of serine/threonine kinase PpkA, the cognate phosphatase PppA, and the 20	
forkhead-associated (FHA) domain-containing proteins (16), which suggests the involvement 21	
of a threonine phosphorylation (TPP) regulatory pathway in these bacteria (17-20). P. 22	
aeruginosa H1-T6SS is post-translationally regulated, positively by PpkA and negatively by 23	
the cognate phosphatase PppA. Such control occurs via threonine phosphorylation at the 24	
Thr362 residue on a FHA domain-containing protein, Fha1, in P. aeruginosa (21) and 25	
	 4	
Serratia marcescens (20). Remarkably, the T6SS inner-membrane protein TssL and not Fha 1	
was identified as the substrate of PpkA first in Agrobacterium tumefaciens (22) and recently 2	
in Vibiro alginolyticus (23). In A. tumefaciens, TssL forms a stable complex with TssM 3	
(4,6,24), which exhibits ATPase activity (5). Phosphorylated TssL recruits Fha to the TssM–4	
TssL complex for T6SS activation (22). In P. aeruginosa, four type VI secretion associated 5	
genes, namely tagQRST, participate in post-translational regulation and act upstream of PpkA 6	
to promote kinase activity and subsequent T6SS-dependent secretion (25,26). Remarkably, 7	
the P. aeruginosa H1-T6SS can also be activated independently of Fha1 phosphorylation and 8	
TPP activity by inactivating a negative regulator, TagF (19). Yet, the molecular basis 9	
underlying the regulatory mechanisms of TagF-mediated T6SS repression has not been 10	
addressed. 11	
A. tumefaciens harbors one T6SS that is activated at both transcriptional and 12	
post-translational levels when sensing acidity (22,27,28). Three T6SS effectors, including one 13	
peptidoglycan amidase (Tae) and two DNases (Tde1 and Tde2), conferring antibacterial 14	
activity, have been identified in this bacterium (29). Autointoxication is prevented through the 15	
production of cognate immunity proteins. In A. tumefaciens, TagF and PppA are encoded as a 16	
fusion protein named TagF-PppA, the overexpression of which abolishes Hcp secretion (22). 17	
In this study, we investigated the TagF-PppA suppression mechanism and how this affects 18	
T6SS-dependent secretion and antibacterial activity in A. tumefaciens. Our data indicate that 19	
the TagF domain alone is sufficient to post-translationally repress the T6SS independently of 20	
TPP. By performing protein–protein interaction studies, we identified that the cytoplasmic 21	
T6SS core component Fha is the binding target for TagF. Using structural modeling, we 22	
identified conserved TagF amino acid residues and demonstrated their importance in Fha 23	
interaction and TagF-mediated repression of T6SS activity. Remarkably, these conserved 24	
residues are also required for P. aeruginosa TagF in repressing the H1-T6SS activity and 25	
	 5	
interaction with Fha1. TagF may have evolved while keeping the Fha protein as a target for 1	
controlling and preventing T6SS assembly. 2	
 3	
Results 4	
Both TagF and PppA domains can repress type VI secretion and antibacterial activity at 5	
post-translational levels in A. tumefaciens 6	
 TPP regulation of T6SS has been demonstrated in only a few bacteria, including A. 7	
tumefaciens strain C58 (22). PpkA (Atu4330), TagF-PppA (Atu4331), and Fha (Atu4335), the 8	
three major components of the TPP pathway, are all encoded within the imp operon (Figure 9	
1A) (22,27,30). Atu4331 is a fusion protein, which contains N- and C-terminal domains 10	
homologous to TagF (DUF2094) (11-219 aa) and PppA (244-470 aa), respectively (thus 11	
named TagF-PppA) (Figure 1B) (22). We previously reported that TagF-PppA plays a 12	
negative role in regulating Hcp secretion when TagF-PppA is overexpressed in A. tumefaciens 13	
(22). However, the molecular mechanism underlying this regulation is unknown. Thus, we 14	
first investigated the impact and respective role of individual domain from the TagF-PppA 15	
chimera on the TagF-PppA-mediated repression activity on T6SS activity. In A. tumefaciens 16	
strain C58, we separately produced the TagF domain located at the N terminus (1-230 aa) and 17	
the C-terminal region (231-471 aa) encompassing the PppA domain (Figure 1B). 18	
Overexpression of TagF-PppA, TagF, and tagged TagF-Strep in C58 completely abolished 19	
type VI secretion (Hcp, Tae and Tde1) (Figure 2A). The T6SS antibacterial activity is also 20	
shut down, as shown by counting surviving E. coli target cells. The number of survivors is 21	
indeed similar as when the attacker is an A. tumefaciens T6SS mutant, ∆tssL (Figures 2B). We 22	
also performed in planta interbacterial competition assay with an A. tumefaciens prey strain 23	
lacking the three T6SS toxins (Tae, Tde1 and Tde2) and cognate immunity proteins, ∆3Tis 24	
(29).	Previous observation showed reduced number of viable prey cells when co-infected with 25	
	 6	
WT C58 (31). Similarly, here the survival of ∆3TIs	was lower after co-infection with WT C58 1	
harboring the vector pTrc200 (V). This was not seen when co-infecting with a T6SS inactive 2	
mutant ∆tssL-carrying pTrc200 (V), or C58 overexpressing the T6SS repressor TagF, i.e. 3	
TagF-PppA, TagF, or TagF-Strep (Figure 2C). Interestingly, overexpression of PppA alone 4	
reduced but did not abolish Hcp secretion (Figure 2A). The antibacterial activity of the 5	
PppA-overexpression strain was also not completely abolished, while modest antibacterial 6	
activity was detected with our in planta interbacterial competition assay (Figure 2C). In 7	
addition, the protein levels of all analyzed T6SS components encoded within the imp 8	
(including TssM, TssL, TssK, Fha, TssC41, TssB, and TssA) and hcp (including ClpV and 9	
VgrG1) operons remained the same in all backgrounds tested, including overexpression of 10	
TagF-PppA, TagF, TagF-Strep, or PppA (Figure 2A). Taken together, these data show that in 11	
A. tumefaciens both TagF and PppA domains contribute the repressor function of TagF-PppA 12	
on T6SS effector secretion and antibacterial activity via a post-translational regulatory 13	
control. 14	
 15	
Both TagF and PppA domains repress T6SS activity independently of PpkA-mediated 16	
TssL phosphorylation 17	
To explore the possible mechanisms of TagF-PppA–mediated T6SS repression at the 18	
post-translational level, we analyzed the impact on TssL phosphorylation. TagF-PppA, TagF, 19	
TagF-Strep, and PppA were overexpressed in the ∆tssL mutant also expressing His-tagged 20	
TssL (TssL-His). This TssL variant is functional and mediates Hcp, Tae and Tde1 secretion 21	
(Figures S1A and S1B) (22). The TssL-His protein was purified by using Ni-NTA resins, and 22	
various A. tumefaciens strains were analyzed. The Phos-tag SDS-PAGE approach was used, 23	
which can detect two TssL-His protein bands, the lower band representing the 24	
	 7	
unphosphorylated TssL-His and the upper band representing the phosphorylated TssL-His 1	
(p-TssL-His) (Figure 3A) (22). In all cases, the TssL-His protein displayed a similar 2	
phosphorylation pattern (Figure 3A), which suggests that neither the full-length nor any 3	
domain of TagF-PppA represses T6SS activity by controlling TssL phosphorylation. 4	
To determine whether the phosphorylation level detected from an overexpressed TssL-His 5	
is representative of an endogenous situation, we generated an antibody that specifically 6	
recognizes phosphorylated TssL (pTssL) (Figure 3B). Phosphorylated TssL protein was 7	
detected as a single protein band and found with the same abundance when comparing WT 8	
C58 and strains overexpressing TagF-PppA, TagF, TagF-Strep, and PppA. However, the 9	
pTssL protein band was not detected in ΔtssL and ΔppkA mutant strains (Figure 3C). We 10	
concluded that TagF-PppA represses T6SS activity independently of TssL phosphorylation in 11	
A. tumefaciens. 12	
It is intriguing that overexpression of PppA domain had no impact on TssL 13	
phosphorylation, which is mediated by PpkA, but still could repress T6SS activity. To 14	
determine that the TPP-independent repression of both TagF and PppA domains is not caused 15	
by secondary effect linked to overexpression, we also examine the T6SS secretion and 16	
antibacterial activity in a strain lacking the entire TPP, i.e. both ppkA and tagF-pppA. We 17	
generated a ∆ppkA∆tagF-pppA strain and separately overexpressed the TagF or PppA domain 18	
in this mutant background. Interestingly, unlike ∆ppkA resulting in decreased type VI 19	
secretion (22), the ∆ppkA∆tagF-pppA mutant retained comparable type VI secretion activity 20	
to that of the WT C58 (Figure 4A). Overexpression of each of TagF or PppA domain in 21	
∆ppkA∆tagF-pppA abolished or greatly reduced the type VI secretion (Figure 4B), suggesting 22	
that both TagF and PppA domains can inhibit type VI secretion in the absence of PpkA. As 23	
expected, the antibacterial activity was also abolished when TagF or PppA domain was 24	
overexpressed in ∆ppkA∆tagF-pppA as shown by counting E. coli survivors and comparison 25	
to what is observed when the attacker is a T6SS mutant, ∆tssL (Figure 4C). Interestingly, 26	
	 8	
while the Hcp and effector (Tde1 and Tae) secretion levels in ∆ppkA∆tagF-pppA was 1	
comparable to that of WT C58 (Figure 4A), only partial antibacterial activity was observed 2	
(Figure 4C). This phenotype is consistent with a previous observation in P. aeruginosa and S. 3	
marcescens, with ∆pppA showing reduced antibacterial activity despite elevated type VI 4	
secretion (20,32,33). These data indicate that both the TagF and PppA domains play a role in 5	
repressing the A. tumefaciens T6SS activity. This control is exerted at a post-translational 6	
level and is independent of PpkA and TssL phosphorylation. 7	
 8	
TagF interacts with the forkhead-associated protein Fha of A. tumefaciens and P. 9	
aeruginosa 10	
Next, we investigated how TagF-PppA represses T6SS activity via a post-translational 11	
and TPP-independent pathway. We hypothesized that TagF-PppA may interact with the T6SS 12	
core component(s) to prevent T6SS activation. One plausible candidate is the 13	
forkhead-associated protein Fha because of its role in recruitment to a membrane-associated 14	
complex both independently and dependently of TPP (19,21,22). Because TagF is the 15	
common repressor known to suppress T6SS independently of TPP in both A. tumefaciens and 16	
P. aeruginosa, we set up experiments to determine whether A. tumefaciens TagF-PppA and P. 17	
aeruginosa TagF can interact with their cognate Fha. Yeast two-hybrid (YTH) experiments 18	
revealed that both A. tumefaciens full-length TagF-PppA and the isolated TagF domain 19	
specifically interact with Fha (Figure 5A). We also detected an interaction between the P. 20	
aeruginosa H1-T6SS-encoded TagF and Fha1 by using both YTH (Figure 5B) and bacterial 21	
two-hybrid (BTH) assays (Figure 5C). The data demonstrate that TagF directly interacts with 22	
Fha likely interfering with its function and thereby preventing type VI secretion in both A. 23	
tumefaciens and P. aeruginosa. 24	
	 9	
 1	
Conserved amino acid residues in TagF are critical for TagF–Fha interaction 2	
Although Fha is the target for TagF in both A. tumefaciens and P. aeruginosa, the two 3	
TagF proteins share only limited amino acid similarity (Figure 6A). Yet, 14 amino acids 4	
residues are highly conserved among various TagF orthologs (Figures 6A and S3A). We 5	
hypothesized that these residues may play important roles in TagF function. The structure of 6	
P. aeruginosa TagF is presented as a homodimer (34). The self-interaction of P. aeruginosa 7	
TagF was also confirmed by BTH and YTH (Figures 5C and S2A). In contrast, the A. 8	
tumefaciens TagF does likely function as a monomer, as supported by several lines of 9	
evidence. First, the TagF protein is mostly a monomer when analyzed by gel filtration in vitro 10	
(Figure 6B). Second, A. tumefaciens TagF lacks the residues required for dimer formation in 11	
P. aeruginosa [Val105 (V105), Leu169 (L169), Leu172 (L172), Ala173 (A173), and Leu195 12	
(L195) in TagFPa] (Figure S3A) (34). Finally, no self-interaction could be found for A. 13	
tumefaciens TagF using YTH (Figure S2B). Other conserved residues are not involved in P. 14	
aeruginosa TagF homodimerization and were thus chosen for site-directed mutagenesis and 15	
characterization of the potential interface with other interacting proteins, namely Fha. A total 16	
of eight conserved residues [Gly8 (G8), Lys9 (K9), Asp15 (D15), Phe16 (F16), Ser79 (S79), 17	
Asp81 (D81), Arg85 (R85), and Pro (P88) of P. aeruginosa TagF] form a specific loop, and 18	
the side chain of Asp30 (D30) is outwardly exposed (Figure 6C). Therefore, these are 19	
potential sites to interact with other proteins. In contrast, Phe60 (F60), Gly74 (G74), and 20	
Leu139 (L139) are located inside the structure or the side chain wrapped in an internal 21	
structure to prevent interaction with other proteins. We generated four mutants with amino 22	
acid substitutions of alanine at GK (G8K9 in P. aeruginosa TagF; G22K23 in A. tumefaciens 23	
TagF), DF (D15F16 in P. aeruginosa TagF; D29F30 in A. tumefaciens TagF), DW (D30W32 24	
in P. aeruginosa TagF; D44W46 in A. tumefaciens TagF), and SDR (S79D81R85 in P. 25	
	 10	
aeruginosa TagF; S93D95R99 in A. tumefaciens TagF) (Figures 6A and 6C). We performed 1	
YTH analysis with the various A. tumefaciens TagF variants to determine the roles of the 2	
substituted residues in the TagF–Fha interaction. The interaction was completely lost in 3	
TagFGK, TagFDW, and TagFSDR mutants (Figure 6D). In contrast, TagFDF and TagFFD with 4	
mutations in two randomly selected non-conserved residues [Phe141Asp142 (F141D142) in A. 5	
tumefaciens TagF] still retained	 full capacity to interact with Fha as compared with the WT 6	
TagF (Figure 6D). Western blot analysis revealed that the protein abundance remained the 7	
same or was even slightly higher for all analyzed TagF variants as compared to the WT TagF 8	
(Figure S3B), which indicates that conserved G22K23, D44W46, and S93D95R99 residues but not 9	
D29F30 of A. tumefaciens TagF are critical for the TagF–Fha interaction. 10	
 11	
Loss of TagF–Fha interaction upon site-directed mutagenesis abolishes the repression of 12	
T6SS activity in A. tumefaciens  13	
To determine whether the TagF–Fha interaction is required for suppressing T6SS 14	
activity, we engineered the previously described mutations in the TagF-Strep variants and 15	
analyzed the impact of their overexpression on type VI secretion. As expected, 16	
overexpression of the WT controls, TagF-Strep or TagFFD-Strep, abolished Hcp, Tae and 17	
Tde1 secretion. Remarkably, the secretion capacity remained high with overexpression of 18	
TagFGK-Strep, TagFDF-Strep, TagFDW-Strep and TagFSDR-Strep in C58 (Figure 7A). Upon 19	
western blot analysis, the protein levels of all TagF variants were comparable to that of WT 20	
TagF-Strep and overexpression did not affect the protein abundance of other T6SS 21	
components (Figure 7A). These data suggest that the conserved residues GK, DW, and SDR 22	
of TagF are critical for TagF-mediated repression of type VI secretion via the TagF–Fha 23	
interaction. Intriguingly, TagFDF retained full binding capacity with Fha but lost the ability to 24	
	 11	
repress type VI secretion, which suggests that D29F30 is not involved in binding Fha but is 1	
required for repressing T6SS activity. As expected, the type VI secretion activity of these 2	
TagF overexpression variants was consistent with their antibacterial activity (Figures 2B and 3	
2C). The survival of E. coli was reduced to a level similar to that with the strain harboring the 4	
empty vector control when TagFGK-Strep was overexpressed in ∆ppkA∆tagF-pppA (Figures 5	
4B and 4C), which confirms that TagFGK-Strep lost the ability to repress T6SS-dependent 6	
antibacterial activity via a PpkA-independent pathway. To ensure the overexpression 7	
phenotypes of the mutant alleles also reflected when expressed at endogenous levels, we 8	
further generated chromosomal tagF-pppA alleles encoding the TagF amino acid substitution 9	
variants and further determined their T6SS suppression activity. All TagF amino acid 10	
substitution variants expressed from chromosomal alleles exhibited enhanced antibacterial 11	
activity (Figure 7B), which is consistent with the de-repressing T6SS activity demonstrated 12	
upon overexpression of these TagF variants (Figures 2B and 2C). However, our secretion 13	
assay could not detect significant difference on secretion levels of Hcp and two effectors (Tae 14	
and Tde1) of all analyzed tagF-pppA mutants as compared to wild-type C58 (Figure S4). 15	
Taken together, our data suggest that TagF negatively regulates T6SS via direct interaction 16	
with Fha in A. tumefaciens. 17	
 18	
Overexpression of TagF causes reduced T6SS protein accumulation and abolishes T6SS 19	
antibacterial activity in P. aeruginosa 20	
We then assessed whether these specific conserved amino acid residues of TagF 21	
required for binding to Fha and T6SS repression in A. tumefaciens are also required in P. 22	
aeruginosa TagF for Fha1Pa interaction and T6SS activity. We generated two alanine 23	
substitution mutants in TagF Pa, namely TagFPa-GK (G8 and K9) and TagFPa-SDR (S79, D81 and 24	
	 12	
R85). Consistent with the results obtained with A. tumefaciens, TagFPa-GK and TagFPa-SDR 1	
mutants lost the interaction with Fha1Pa even though their expression level was comparable to 2	
that of WT TagFPa in yeast (Figures 8A and S3C). To determine whether the TagFPa–Fha1Pa 3	
interaction is critical for TagF-dependent H1-T6SS repression, WT TagFPa, Strep-tagged WT 4	
TagFPa and the TagFPa-GK and TagFPa-SDR variants were expressed from pRL662 in the P. 5	
aeruginosa ∆retS mutant, a constitutively H1-T6SS active strain (35). As expected, Hcp1 and 6	
Tse3 were secreted into the culture medium of ∆retS harboring the vector pRL662 (V), but 7	
H1-T6SS secretion was greatly reduced when TagFPa or TagFPa-Strep was overexpressed 8	
(Figure 8B). Furthermore, overexpression of TagFPa-GK-Strep or TagFPa-SDR-Strep did not 9	
repress Hcp1 and Tse3 secretion. Interestingly, in contrast to A. tumefaciens where 10	
overexpressed TagF mutant variants come in level comparable to the overexpressed WT form, 11	
in P. aeruginosa we observed significantly higher levels of WT TagFPa-Strep as compared 12	
with TagFPa-GK-Strep or TagFPa-SDR-Strep (Figure 8B). Furthermore, protein levels of all 13	
analyzed T6SS components (including secreted proteins Hcp1 and Tse3 and structural 14	
proteins TssB1 and TagJ1) were significantly reduced upon overexpression of WT TagF 15	
(TagFPa or TagFPa-Strep). Accordingly, protein levels of these T6SS components were 16	
restored to near-WT levels in the presence of TagFPa-GK-Strep and TagFPa-SDR-Strep in P. 17	
aeruginosa (Figure 8B). 18	
Next, we performed antibacterial activity and showed that when TagFPa-Strep was 19	
overexpressed in PAK∆retS, E. coli survival is similar to that for the T6SS-defective 20	
PAK∆retS∆tssB1 mutant. In contrast, the expression of TagFPa-GK-Strep and TagFPa-SDR-Strep 21	
conferred similar antibacterial activity as that of PAK∆retS (Figure 8C). Because the reduced 22	
protein level/stability of both TagFPa-GK-Strep and TagFPa-SDR-Strep is associated with loss of 23	
ability to interact with Fha1Pa, we tested whether the presence or absence of Fha1Pa affected 24	
TagF abundance. Strikingly, TagFPa-Strep protein level was significantly reduced in 25	
PAK∆retS∆H1, which lacks endogenous Fha1Pa, as compared with PAK∆retS (Figure 8D). 26	
	 13	
TagFPa-Strep protein levels could be partially restored upon co-expression of TagFPa-Strep 1	
and Fha1Pa-HA in PAK∆retS∆H1 (Figure 8D), which suggests that Fha1Pa may play a role in 2	
stabilizing TagFPa in P. aeruginosa. Taken together, our results indicate that the TagF domain 3	
represses T6SS activity via interaction with Fha but with distinct mechanisms when 4	
comparing A. tumefaciens and P. aeruginosa. 5	
 6	
Discussion 7	
In the present study, we characterized the A. tumefaciens TagF-PppA and P. aeruginosa 8	
TagF and provide compelling evidence that TagF specifically interacts with Fha to repress 9	
type VI secretion and antibacterial activity independently of TPP. The loss of interaction with 10	
Fha is associated with loss of repression of T6SS activity in both cases. Yet, we observed 11	
differences in the nature and impact of TagF and its variants in repressing T6SS. This may 12	
have strategic consequences on how bacteria from various species communicate and respond 13	
to each other during T6SS-dependent bacterial warfare. 14	
One remarkable difference is that TagF–Fha interaction has a different impact on T6SS 15	
protein abundance between A. tumefaciens and P. aeruginosa. A similar protein abundance of 16	
all TagFAt or TagFAt-Strep overexpressed (WT and all mutants) was observed in A. 17	
tumefaciens. In contrast, in P. aeruginosa, the protein level was significantly lower for 18	
TagFPa-GK-Strep or TagFPa-SDR-Strep than WT TagFPa-Strep (Figures 2A, 7A, and 8B). 19	
Furthermore, all analyzed T6SS proteins accumulated to a similar level in the presence or 20	
absence of endogenous or overexpressed TagFAt in A. tumefaciens (Figures 2A and 7A). 21	
However, the protein levels of P. aeruginosa H1-T6SS components (including secreted 22	
proteins Hcp1 and Tse3 and structural proteins TssB1 and TagJ1) were reduced with TagFPa 23	
or TagFPa-Strep overexpression but restored to near-WT levels in the presence of mutant 24	
TagFPa-GK-Strep or TagFPa-SDR-Strep (Figure 8B). Previous studies in P. aeruginosa suggested 25	
	 14	
that TagFPa-mediated T6SS repression is mediated via a post-translational regulation 1	
mechanism (19). The evidence is based on the lack of influence on the expression of 2	
lacZ-translational fusion to fha1 or tssA1 and on the levels of two secreted proteins, Hcp and 3	
Tse1, in a ∆tagF mutant, which activates Hcp and Tse1 secretion. Instead of analyzing a tagF 4	
mutant here, we used strains overexpressing TagF, and our data support that the P. 5	
aeruginosa TagF-mediated post-translational repression occurs via influencing the protein 6	
stability of T6SS components when TagFPa is expressed in excess amounts. Taken together, 7	
Fha is a common target for TagF in repressing T6SS via post-translational regulation in both 8	
A. tumefaciens and P. aeruginosa, but each have different strategies to exert this repression 9	
activity. 10	
 The role of Fha in activating T6SS in both TPP-dependent and -independent pathways 11	
may provide some clues to understand the mode of action by which TagF represses T6SS 12	
activity. Fha1 but not its phosphorylated form is required for ClpV1Pa foci formation and 13	
TagFPa-mediated de-repression of type VI secretion in	 P. aeruginosa (19,21). Also, Fha 14	
protein is a core component for T6SS in several bacteria lacking PpkA, PppA, and TagF 15	
(21,22,30,36). Therefore, in addition to functioning as a scaffold protein specifically binding a 16	
phosphothreonine protein, Fha may also serve as a core T6SS component likely via 17	
interaction with one or multiple T6SS components to activate T6SS assembly and secretion. 18	
TssM could be such a candidate because Fha1 foci formation is lost in a P. aeruginosa 19	
∆icmF(tssM) mutant (37). In A. tumefaciens, Fha specifically interacts with TssL at 20	
phosphothreonine 14 (pT14) to associate with the TssM–TssL inner membrane complex and 21	
recruit Hcp to interact with TssL for activating type VI secretion (4,22). Together with our 22	
current knowledge of the T6SS assembly pathway (2,10,38), these studies indicate that Fha 23	
plays a key role in T6SS assembly at step(s) before recruitment of Hcp and TssB–TssC for 24	
tail polymerization. In A. tumefaciens, only WT TssL but not a TssL variant with the T14A 25	
amino acid substitution could interact with Fha, as assessed by pulldown assay (22). Thus, 26	
	 15	
Fha may interact with other core component(s) of the T6SS in addition to TssL or Fha itself, 1	
especially when PpkA is absent or not active. If so, TagF may compete with other T6SS core 2	
components for interacting with Fha and thereby prevent Fha from binding to a T6SS 3	
membrane-associated complex for stability (in P. aeruginosa) or activation of T6SS assembly 4	
(in A. tumefaciens). 5	
Of note, the conserved G22K23, D44W46, and S93D95R99 residues but not D29F30 of A. 6	
tumefaciens TagF are critical for the TagF–Fha interaction but all are required for repressing 7	
T6SS activity. This result led us to propose that D29F30 may repress T6SS function 8	
independently of binding to Fha. TagF may target Fha in repressing T6SS activity in two 9	
steps. The first step is to bind Fha via an interface involving G22K23, D44W46, and S93D95R99. 10	
Upon binding, TagF interferes with Fha recruitment to the membrane-associated complex for 11	
T6SS activation via D29F30 residues. Alternatively, it is possible that TagF can also target 12	
other T6SS components in addition to Fha. Future work to elucidate the molecular details 13	
underlying how TagF-Fha interaction influences T6SS activity or identifying additional 14	
TagF-interacting partners may provide answers to distinguish between two possible 15	
mechanisms. 16	
Combining previous (19,21,22) and current findings, we propose distinct models for 17	
TagF-mediated T6SS repression in A. tumefaciens and P. aeruginosa (Figure 9). In WT A. 18	
tumefaciens when PpkA is active, the level of endogenous TagF-PppA is very low and the 19	
protein does not bind to Fha, with no or little repression activity observed because Fha would 20	
then bind to pTssL for triggering T6SS assembly and secretion (T6SS ON shown in the upper 21	
left panel of Figure 9). On sensing an unknown signal, which may cause high accumulation of 22	
TagF-PppA or suppression of the TPP pathway, TagF-PppA can interact with Fha via its 23	
TagF domain to prevent it from binding to the membrane-associated complex and thus 24	
preventing T6SS activation (T6SS OFF shown in the upper right panel of Figure 9). Because 25	
	 16	
TssM and TssL can form an inner-membrane complex in absence of TssL phosphorylation 1	
(4,22), the TssM–TssL complex and the associated baseplate complex likely remain properly 2	
assembled in the membrane when T6SS is suppressed by TagF-PppA. However, Hcp and 3	
TssBC may not be polymerized into the tail-like structure, and effector proteins are not loaded 4	
on the VgrG-PAAR spike for secretion. Because type VI secretion can be restored to the WT 5	
level in the ∆ppkA∆tagF-pppA mutant (Figure 4A), Fha likely also functions as a core T6SS 6	
component via interaction with one or multiple T6SS components to activate T6SS assembly 7	
and secretion in the absence of PpkA and TagF-PppA. This proposed mechanism also 8	
explains the previous observation that type VI secretion is highly attenuated but not 9	
completely abolished in the absence of PpkA (∆ppkA) (22,30), because endogenous 10	
TagF-PppA, albeit at a low level, can bind Fha, and only a fraction of the Fha pool is 11	
available for recruitment to the T6SS core complex. 12	
In P. aeruginosa, type VI secretion is significantly enhanced in ∆pppA or ∆tagF as 13	
compared with the parental strain, and PppA phosphatase negatively regulates type VI 14	
secretion in a TPP-dependent manner, whereas TagF represses type VI secretion 15	
independently of TPP (19,21). Thus, in WT P. aeruginosa strain harboring both TPP 16	
components and TagF, type VI secretion remains at low levels likely because of a series of 17	
phosphorylation and dephosphorylation events as well as TagF interaction with a fraction of 18	
the Fha1 pool (T6SS ON shown in the lower left panel of Figure 9). When TagF is expressed 19	
in excess amounts, TagF interacts with Fha to prevent it from binding to T6SS components 20	
and thus from activating T6SS assembly and subsequent secretion. Failure of recruiting Fha1 21	
to the membrane-associated T6SS complex may send out a signal to trigger degradation of 22	
cytoplasmic T6SS components and effectors (T6SS OFF shown in the lower right panel of 23	
Figure 9). Our current study may also provide an explanation for the enhanced T6SS secretion 24	
and antibacterial activity in a ∆tagF mutant in the presence or absence of PpkA (19,21). 25	
	 17	
Because Fha1 protein itself but not its phosphorylation is required for ClpV1Pa foci formation 1	
(19,21), non-phosphorylated Fha1 may remain active in binding membrane-associated T6SS 2	
component(s), thus resulting in T6SS assembly and secretion in P. aeruginosa. With no TagF 3	
functionally available (i.e., in the absence of the protein or presence of a TagF mutant losing 4	
Fha1 binding activity), all Fha1 is available for activating T6SS assembly and secretion. 5	
In conclusion, our proposed molecular model may provide answers to the long-standing 6	
question of how TagF mediates T6SS repression. We present compelling evidence suggesting 7	
that TagF specifically interacts with Fha and that such binding prevents Fha from recruitment 8	
to a T6SS membrane-associated complex. The TagF–Fha interaction has different impact in 9	
different bacteria but ultimately prevents successful T6SS assembly. This study adds to our 10	
understanding of how bacteria deploy TPP-dependent activation and TPP-independent 11	
TagF-mediated repression mechanisms to control T6SS. 12	
 13	
Experimental procedures 14	
Bacterial strains, plasmids, and growth conditions 15	
Strains, plasmids, and primer sequences used in this study are described in Tables S1 and S2. 16	
The growth conditions were described in detail in Supporting Information S1. 17	
Plasmid construction and generation of in-frame deletion mutants 18	
All in-frame deletion mutants were generated in A. tumefaciens C58 via double crossover 19	
using the suicide plasmid pJQ200KS (39) as previously described (4,27). The detailed 20	
procedures for the construction of plasmids and mutant strains are described in Supporting 21	
Information S1. 22	
Antibody production 23	
	 18	
The specific antibody for phosphorylated TssL (pTssL) was generated against the 15-mer 1	
peptide (7-SSWQDLPpTVVEITEE-21) containing the phosphorylated Thr 14 residue (22). 2	
The pTssL epitope located at the N-terminal region of TssL was used for polyclonal antibody 3	
production in rabbits. 4	
A. tumefaciens type VI secretion and antibacterial competition assays 5	
Type VI secretion assay was performed as described previously (4,27,29,30). To study type 6	
VI secretion from A. tumefaciens grown in liquid medium, A. tumefaciens cells were grown in 7	
liquid 523 medium for 16 hr at 25 °C. Cells were harvested and OD600 was adjusted to 0.1, A. 8	
tumefaciens cells continued to grow in liquid AB-MES medium (pH 5.5) (40) at 25 °C for 6 9	
hr. The cell suspension was centrifuged at 10,000 x g for 15 min at 4 °C; the resulting 10	
supernatant was concentrated by trichloroacetic acid (TCA) precipitation and Hcp, Tae, and 11	
Tde1 secretion monitored as previously described (4,27). A. tumefaciens antibacterial activity 12	
assay using E. coli as target cells was performed as previously described (29). In brief, 13	
overnight grown A. tumefaciens and E. coli strains harboring appropriate plasmids were 14	
adjusted to OD600 0.1 and incubated at 25oC for 4-5 hr prior to co-incubation. A. tumefaciens 15	
and E. coli cells were harvested and OD600 was adjusted, mixed at 1:30 ratio (OD600 0.01:0.3) 16	
and spotted onto LB agar plates. Where applicable, the mixture was spotted onto a LB agar 17	
plate containing 0.5 mM IPTG to induce expression from the pTrc200 plasmid. After 16 hr 18	
post-incubation at 25 oC, the spots were harvested, serially diluted and plated on LB agar plate 19	
containing appropriate antibiotic to quantify surviving E. coli cells by counting 20	
colony-forming units (CFUs). In planta bacterial competition assay was performed as 21	
previously described (29). Briefly, A. tumefaciens strains were transformed with gentamycin 22	
(Gm), resistance conferred by the pRL662 plasmid or spectinomycin (Sp), resistance 23	
conferred by the pTrc200 plasmid, for selecting surviving cells. The attacker (OD600 5) and 24	
target (OD600 0.5) strains were mixed in 1/2 Murashige and Skoog (MS) medium (pH 5.7) at a 25	
	 19	
10:1 ratio and infiltrated into leaves of 6- to 7-week-old N. benthamiana plants by use of a 1	
needleless syringe. After 24 hr	 incubation at room temperature, the infiltrated spot was 2	
punched out, ground in 0.9% NaCl, serially diluted, and plated in triplicates on LB agar 3	
containing appropriate antibiotic to select for the target cells. All assays were performed with 4	
at least two independent experiments and each with two biological replicates; or three 5	
independent experiments and each with one or two biological replicates. 6	
P. aeruginosa type VI secretion and antibacterial competition assays 7	
P. aeruginosa type VI secretion assay was performed as previously described (41). In brief, P. 8	
aeruginosa strains harboring appropriate plasmids were grown in tryptone soy broth (TSB) 9	
overnight at 37 °C under agitation. Cells were harvested and sub-cultured to an OD600 of 0.1, 10	
then growth was continued in TSB to early stationary phase at 37 °C for 4-5 hr to OD600 5. 11	
Cells were separated from culture supernatants by centrifugation at 4000 x g at 4 °C. Cells 12	
were directly resuspended in 1 x SDS sample buffer. Ten-fold of concentrated P. aeruginosa 13	
culture supernatant was prepared as follows. Proteins of the culture supernatant were 14	
precipitated using 6 M trichlo-roacetic acid (TCA) (Sigma) at a ﬁnal TCA concentration of 15	
10%. Protein pellets were washed in 90% acetone, dried and suspended in 1 x SDS sample 16	
buffer and incubated at 96 ºC for 20 min and analyzed by SDS-PAGE. P. aeruginosa 17	
antibacterial activity assay using E. coli as target cells was performed as previously described 18	
(42). In brief, overnight cultures of indicated P. aeruginosa strains were incubated with 19	
overnight cultures of equivalent bacterial numbers of E. coli containing the plasmid pCR2.1 20	
(carrying the lacZ gene) in a 1:1 ratio on LB agar for 5 hr at 37 °C. In addition, P. aeruginosa 21	
and E. coli strains grow alone on LB agar for 5 hr at 37 °C served as negative growth controls. 22	
Subsequently, patches of bacteria were collected, resuspended in LB broth and dilution series 23	
ranging from 100 to 10-7 were plated in triplicate on LB supplemented with 100 mg/mL 24	
5-bromo- 4-chloro-indolyl-β-D-galactopyranoside (X-gal, Invitrogen) allowing for 25	
	 20	
colorimetric detection of lacZ-positive E. coli survivors.	 For quantitative analysis of the 1	
amount of E. coli survivors, the spots were harvested, serially diluted and plated on LB agar 2	
plate containing X-gal and appropriate antibiotic to quantify surviving E. coli cells by 3	
counting colony-forming units (CFUs). Data represent mean ± standard deviation (SD) of all 4	
biological replicates. 5	
Yeast two-hybrid assay 6	
The Matchmaker yeast two-hybrid system was used as instructed (Clontech, Mountain View, 7	
CA) and as previously described (30). Each of the plasmid pairs were co-transformed into 8	
Saccharomyces cerevisiae strain AH109. The transformants were selected by their growth on 9	
synthetic dextrose (SD) minimal medium lacking tryptophan (Trp) and leucine (Leu) (SD-WL 10	
medium). The positive interaction of expressed fusion proteins was then determined by their 11	
growth on SD lacking Trp, Leu, adenine (Ade), and histidine (His) (SD-WLHA medium) at 12	
30 oC for at least 2 days. 13	
Total protein extraction from yeast 14	
In brief, to prepare the total protein from yeast (43), overnight grown yeast strains harboring 15	
appropriate plasmids were sub-cultured at 28 °C in the same medium for further growth to 16	
OD600 0.4-0.6. Yeast cells were harvested, 100 µl of protein extraction buffer containing 0.1% 17	
NP-40, 250 mM NaCl, 50 mM Tris-HCl (pH7.5), 5 mM EDTA (pH8.0), 1 mM DTT, 2 x 18	
protease inhibitor cocktails (Roche) and 4 mM PMSF, and 50 µL of acid-washed glass beads 19	
(Sigma-Aldrich) were added. The cells were broken by vortex at highest speed for 30 seconds, 20	
then tubes placed on ice for 30 seconds. The same procedure was repeated for 6 times to make 21	
sure	cells have been completely broken. The supernatant above the glass beads was collected 22	
(the 1st cell extract). Then, 50 µL of protein extraction buffer was added to wash the tube 23	
containing broken cells and glass beads by vortexing at highest speed for 30 seconds. The 24	
	 21	
supernatant above the glass beads was collected again (the 2nd cell extract). The two extracts 1	
were mixed together and the final protein extract was centrifuged at 13,000 x rpm for 5 min at 2	
4 °C; the resulting supernatant was collected, and protein concentration was measured. An 3	
equal volume of 2 x SDS loading buffer was added to the final protein sample and incubated 4	
at 96 ºC for 20 min and analyzed by SDS-PAGE. 5	
Bacterial two-hybrid assay 6	
Bacterial two-hybrid (BTH) assay was performed as previously described (44). In brief, DNA 7	
fragments encoding the protein of interest were ampliﬁed by PCR, adding appropriate 8	
restriction sites into the primers, using P. aeruginosa PAK genomic DNA. DNA fragments 9	
encoding the proteins or protein domains of interest were cloned into plasmids pKT25 and 10	
pUT18C, which each encode for complementary fragments of the adenylate cyclase enzyme, 11	
as previously described (44), resulting in constructs expressing N-terminal fusion of the 12	
protein of interest with the T25 or T18 subunit of adenylate cyclase. Recombinant pKT25 and 13	
pUT18C plasmids were co-transformed into the E. coli DHM1 strain, which is devoid of 14	
adenylate cyclase, and transformants were spotted onto LB agar plates (Difco) supplemented 15	
with 40 mg/mL X-gal, in	presence of 100 mg/mL ampicillin, 50 mg/mL kanamycin and 1 mM 16	
IPTG. Positive interactions were identiﬁed as blue colonies on LB agar plates containing 17	
X-gal after 48 hr incubation at 30 °C. The experiments were performed at least in duplicate, 18	
and a representative result is shown. 19	
β-galactosidase assay 20	
For quantitative analysis of BTH interactions, β-galactosidase activity of co-transformants 21	
scraped from LB agar plates containing X-gal was measured as described previously and 22	
activity was calculated in Miller units (45,46).  23	
Statistics analysis 24	
	 22	
Data represent mean ± standard error (SE) of all biological replicates. Statistics was 1	
calculated by one-way ANOVA and Tukey’s honestly significance difference (HSD) test 2	
(http://astatsa.com/OneWay_Anova_with_TukeyHSD/) and the significant difference was 3	
indicated (P <0.01 or P <0.05). 4	
Dephosphorylation and Phos-tag SDS-PAGE analyses 5	
Dephosphorylation analysis by calf intestinal alkaline phosphatase (CIAP) was performed 6	
according to the user manual (New England Biolabs, Beverly, MA, USA) with minor 7	
modifications as described previously (22). Equal amounts of Ni-NTA resins with purified 8	
TssL-His isolated from various A. tumefaciens strains were resuspended in 1 X CIAP buffer 9	
containing 100 mM NaCl, 50 mM Tris-HCl (pH 7.9), 10 mM MgCl2, 1 mM DTT, and 1 X 10	
protease inhibitor cocktail (EDTA-free) with CIAP at 1 unit per µg of protein. The protein 11	
samples treated with or without CIAP were incubated at 37 °C for 90 min. An equal volume 12	
of 2X SDS loading buffer was added and incubated at 96 ºC for 20 min and analyzed by 13	
Phos-tag SDS-PAGE. The Phos-tag SDS-PAGE analysis was performed according to the user 14	
manual for Phos-tag Acrylamide AAL-107 (Wako Pure Chemical Industries, Osaka, Japan) 15	
with minor modifications as described previously (22). Protein samples were separated on 7% 16	
polyacrylamide gels containing 0.35 M Bis-Tris-HCl (pH 6.8), 35μM Phos-tag Acrylamide 17	
AAL-107, and 100 µM ZnCl2, with electrophoresis conducted at 40 mA/gel under a 18	
maximum voltage of 90V in a cold room. After electrophoresis, Phos-tag gels were washed 19	
with transfer buffer (25 mM Tris, 192 mM glycine, 20% methanol) containing 1 mM EDTA 20	
for 15 min with gentle shaking followed by a second wash in transfer buffer without EDTA 21	
for 15 min. The gels were washed with transfer buffer containing 1% SDS for 15 min before 22	
transfer to PVDF membranes with a submarine blotting apparatus. 23	
Protein purification and gel filtration analysis 24	
	 23	
N-terminal His-tagged TagF 1-214 aa proteins were expressed in E. coli BL21 (DE3) cells 1	
with the plasmid pET28a(+)-TagF 1-214. E. coli cells were grown in LB medium in the 2	
presence of kanamycin (20 µg/mL) at 37 °C until the cell density reached to an OD600 of 3	
0.6-0.8. The cultures were induced with 1 mM isopropyl β-D-thiogalactopyranoside (IPTG) 4	
for 16-20 hr at 16 °C to induce production of His-tagged TagF 1-214 aa proteins. The cells 5	
were harvested by centrifugation followed by snap freezing by liquid nitrogen and stored at 6	
-80 °C. Frozen bacterial pellets were resuspended with the lysis buffer (150 mM sodium 7	
chloride, 10 mM imidazole, and 50 mM Tris-HCl pH 7.5), and then the cells were lysed by 8	
microfluidizer. The cell lysate was clarified by centrifugation at 20,000 rpm for 40 min at 4 9	
°C, and the supernatant was loaded onto a Ni-NTA column (GE Healthcare, USA) 10	
pre-equilibrated with the lysis buffer. The column was washed with the washing buffer (150 11	
mM sodium chloride, 80 mM imidazole, and 50 mM Tris-HCl pH 7.5), and the bound protein 12	
was eluted by the elution buffer (150 mM sodium chloride, 300 mM imidazole, and 50 mM 13	
Tris-HCl pH 7.5). The TagF 1-214 aa proteins were further analyzed by	 size-exclusion 14	
chromatography using a Superdex 75 16 x 60 column through fast protein liquid 15	
chromatography (FPLC) system (GE Healthcare). The column was equilibrated with 2 16	
column volumes of buffer containing 50 mM Tris-HCl (pH 7.5), and 150 mM NaCl. To 17	
determine molecular weight, a parallel column was run with protein standards. The elution 18	
profiles were recorded as absorbance at 280 nm. 19	
Western blot analysis 20	
Western blot analysis was performed as previously described (40) with the primary polyclonal 21	
pTssL antibody produced in this study and those against proteins (PpkA, TagF-PppA, TssK, 22	
Fha, TssC41, TssB, TssA, ClpV, Tae, VgrGs, RpoA)(30), TssL (4), TssM (4), Hcp (27), ActC 23	
(47), Tde1(29), P. aeruginosa Hcp1, TssB1, TagJ1, and Tse3 (44), polyclonal antibodies 24	
against His (Sigma-Aldrich), and monoclonal antibodies against HA (Sigma-Aldrich),	 the 25	
	 24	
beta subunit of RNA polymerase (RNAP) (Neoclone), c-Myc (Sigma-Aldrich) or Strep 1	
(IBA-Life Sciences, Goettingen, Germany), followed by incubation with a secondary 2	
antibody, horseradish peroxidase-conjugated goat anti-rabbit IgG (chemichem), and detection 3	
by use of the Western Lightning System (Perkin Elmer, Boston, MA). Chemiluminescent 4	
bands were visualized on X-ray film (GE Healthcare). 5	
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Figure legends 21	
Figure 1 A. tumefaciens C58 t6ss gene clusters and TagF-pppA domain organization. (A) 22	
The imp operon (atu4343 to atu4330), hcp operon (atu4344 to atu4352), and vgrG2 in A. 23	
tumefaciens strain C58 was designated tss or tag based on nomenclature proposed by Shalom 24	
et al. (2007) (48) and specific names derived from Lin et al. (30) and Bondage et al. (31). (B) 25	
TagF-PppA domain organization according to information from the NCBI database 26	
(http://www.ncbi.nlm.nih.gov/). TagF-PppA is predicted as a cytoplasmic protein (1-471 aa) 27	
with an N-terminal conserved TagF (DUF2094) domain (11–219 aa) and a C-terminal PppA 28	
(PP2Cc) domain (244-470 aa).  29	
Figure 2 Both TagF and PppA domains can repress type VI secretion and antibacterial 30	
activity at post-translational levels in A. tumefaciens. (A) Type VI secretion analysis. 31	
	 29	
Western blot analysis of total (T) and secreted (S) proteins isolated from wild-type C58 1	
harboring the vector pTrc200 (V) or	various overexpressing plasmids grown in AB-MES (pH 2	
5.5) liquid culture with specific antibodies. The non-secreted protein ActC and RNA 3	
polymerase α subunit RpoA were internal controls. The proteins analyzed and sizes of 4	
molecular weight standards are on the left and right, respectively, and with arrowheads when 5	
necessary. FL, full length	TagF-PppA protein. (B) A. tumefaciens antibacterial activity assay 6	
against E. coli. The A. tumefaciens wild-type C58 harboring the vector pTrc200 (V) or 7	
various overexpressed plasmids or ΔtssL mutant harboring the vector pTrc200 (V) was 8	
co-cultured on LB agar with E. coli strain DH10B cells harboring the plasmid pRL662. (C) A. 9	
tumefaciens intraspecies competition in planta. The A. tumefaciens wild-type C58 harboring 10	
the vector pTrc200 (V) or various overexpressed plasmids or ΔtssL mutant harboring the 11	
vector pTrc200 (V) was used as attacker strain to mix with the target strain Δ3TIs harboring 12	
pRL662 and infiltrated into N. benthamiana leaves. (B)(C) Data are mean ± standard 13	
deviation (SD) of at least 3 biological replicates. Different letters above the bar indicate 14	
statistically different groups of strains [P <0.01 for (B), P<0.05 for (C)] based on CFUs of the 15	
surviving target cells. 16	
Figure 3 Both TagF and PppA domains repress T6SS activity independently of 17	
PpkA-mediated TssL phosphorylation pathway in A. tumefaciens. (A) Phos-tag 18	
SDS-PAGE analysis to detect the phosphorylation status of TssL-His. Western blot analysis 19	
of the same volumes of Ni-NTA resins (10 µL) associated with TssL-His from different 20	
strains treated with (+) or without (-) CIAP and examined by a specific antibody against 21	
6xHis. Total protein isolated from ∆tssL was a negative control. Phos-tag SDS-PAGE 22	
revealed the upper band indicating the phosphorylated TssL-His (p-TssL-His) and lower band 23	
indicating unphosphorylated TssL-His. (B)(C) Western blot analysis of the endogenous 24	
phosphorylation status of TssL (pTssL). Western blot analysis of total proteins isolated from 25	
	 30	
wild-type C58 or ∆ppkA or ∆tssL or C58 harboring the vector pTrc200 (V) or various 1	
overexpressing plasmids grown in AB-MES (pH 5.5) liquid culture with specific antibodies. 2	
The specific antibody for phosphorylated TssL (pTssL) was generated against the 15 mer 3	
peptide (7-SSWQDLPpTVVEITEE-21), with phosphorylated Thr 14 of TssL underlined. 4	
RNA polymerase α subunit RpoA was an internal control. The proteins analyzed and 5	
molecular weight standards are on the left and right, respectively, and indicated with an 6	
arrowhead when necessary. FL, full-length TagF-PppA proteins. 7	
Figure 4 TagF represses T6SS activity independent of the TPP pathway in A. 8	
tumefaciens. (A)	 (B) Type VI secretion analysis. Western blot analysis of total (T) and 9	
secreted (S) proteins isolated from wild-type C58 harboring the vector pTrc200 (V) or ∆tssL 10	
harboring the vector pTrc200 (V) or ∆ppkA∆tagF-pppA harboring various overexpressing 11	
plasmids grown in AB-MES (pH 5.5) liquid culture with specific antibodies. The 12	
non-secreted protein ActC and RNA polymerase α subunit RpoA were internal controls. The 13	
proteins analyzed and molecular weight standards are on the left and right, respectively, and 14	
with an arrowhead when necessary. (C) A. tumefaciens antibacterial activity assay against E. 15	
coli. The A. tumefaciens wild-type C58 harboring the vector pTrc200 (V) or ∆tssL harboring 16	
the vector pTrc200 (V) or ∆ppkA∆tagF-pppA harboring various overexpressing plasmids was 17	
co-cultured on LB agar with E. coli strain DH10B cells harboring pRL662. Data are mean ± 18	
standard deviation (SD) of at least 3 biological replicates. Different letters above the bar 19	
indicate statistically different groups of strains (P <0.01) based on CFUs of the surviving 20	
target cells. 21	
 22	
Figure 5 TagF directly interacts with Fha of A. tumefaciens and P. aeruginosa. (A)(B) 23	
Yeast two-hybrid protein–protein interaction results. SD-WL medium (SD minimal medium 24	
	 31	
lacking Trp and Leu) was used for the selection of plasmids. SD-WLHA medium (SD 1	
minimal medium lacking Trp, Leu, His, and Ade) was used for the auxotrophic selection of 2	
bait and prey protein interactions. The positive interaction was determined by growth on 3	
SD-WLHA medium at 30 oC for at least 2 days. The positive control (+) showing interactions 4	
of SV40 large T-antigen and murine p53 and negative control (vector) are indicated. (C)	5	
Bacterial two-hybrid analysis. Various combinations of recombinant pKT25 and pUT18C 6	
plasmids harboring P. aeruginosa TagFPa or Fha1Pa proteins were co-transformed into E. coli. 7	
A graphical representation of the β-galactosidase activity from co-transformants is shown, the 8	
plasmid combinations are indicated below, and images of corresponding	E. coli spots on LB 9	
agar plates containing X-gal are displayed at the top. The strength of the interaction was 10	
investigated by measuring the β-galactosidase activity of cells. The average activity in Miller 11	
units is indicated. Experiments were carried out in duplicate, and data are mean ± standard 12	
deviation (SD). Different letters above the bar indicate statistically different groups (P <0.01). 13	
T18, empty-vector pUT18C; T25, empty-vector pKT25. 14	
Figure 6 Conserved amino acid residues of TagF are critical for TagF–Fha interaction 15	
in A. tumefaciens. (A) Amino acid sequence alignment of TagF or TagF domain orthologs 16	
from selected bacterial species. Conserved amino acid residues are highlighted in black and 17	
those used for mutagenesis are indicated with an asterisk. Sequences were aligned and 18	
highlighted by use of ClustalW2 (http://www.ebi.ac.uk/Tools/msa/clustalw2/). Part of the 19	
aligned result is shown here, and the fully aligned result and full information for bacterial 20	
strains and protein accession numbers are in Figure S3A. (B) Agrobacterium TagF protein is 21	
present as a monomer on gel filtration analysis in vitro. Purified His-tagged TagF domain 22	
(1-214 aa) was analyzed by SDS-PAGE. The proteins analyzed and molecular weight 23	
standards are on the right and left, respectively. His-tagged TagF proteins were further 24	
analyzed by use of Superdex 75 16 x 60 column and the elution profiles were recorded as 25	
	 32	
absorbance at 280 nm showing His-tagged TagF elutes as a single peak (~26 kDa monomer). 1	
(C) Relative positions of the conserved amino acids residues in P. aeruginosa TagFPa protein 2	
revealed as a monomer crystal structural information according to the X-ray crystal structure 3	
of P. aeruginosa TagF monomer (34). The corresponding conserved amino acid residues of A. 4	
tumefaciens TagF are indicated in parenthesis. (D) Yeast two-hybrid protein–protein 5	
interaction results with Fha and various TagF proteins. SD-WL medium (SD minimal 6	
medium lacking Trp and Leu) was used for selecting plasmids. SD-WLHA medium (SD 7	
minimal medium lacking Trp, Leu, His, and Ade) was used for the auxotrophic selection of 8	
bait and prey protein interactions. The positive interaction was determined by growth on 9	
SD-WLHA medium at 30 oC for at least 2 days. The positive control (+) showing interactions 10	
of SV40 large T-antigen and murine p53 and negative control (vector) are indicated. 11	
Figure 7 Conserved amino acid residues of TagF are required for repressing type VI 12	
activity in A. tumefaciens. (A) Western blot analysis of total (T) and secreted (S) proteins 13	
isolated from wild-type C58 harboring the vector pTrc200 (V) or various TagF-Strep 14	
overexpressed plasmids grown in AB-MES (pH 5.5) liquid culture with specific antibodies. 15	
The non-secreted protein ActC and RNA polymerase α subunit RpoA were internal controls. 16	
The proteins analyzed and molecular weight standards are on the left and right, respectively. 17	
(B) A. tumefaciens antibacterial activity assay against E. coli. The A. tumefaciens wild-type 18	
C58 or ∆tssL or chromosomally encoded tagF-pppA variants, including tagF-pppA with 19	
substitutions in tagF domain (tagFGK-pppA, tagFDW-pppA, and tagFSDR-pppA) was co-cultured 20	
on LB agar with E. coli strain DH10B cells harboring the plasmid pRL662. Data are mean ± 21	
standard deviation (SD) of at least 3 biological replicates. Different letters above the bar 22	
indicate statistically different groups of strains (P <0.05) based on CFUs of the surviving 23	
target cells. 24	
	 33	
Figure 8 Conserved amino acid residues of TagFPa critical for TagFPa–Fha1Pa interaction 1	
are required for repressing H1-T6SS activity in P. aeruginosa. (A) Yeast two-hybrid 2	
protein–protein interaction results with P. aeruginosa Fha1 and various P. aeruginosa TagF 3	
proteins. SD-WL medium (SD minimal medium lacking Trp and Leu) was used for selecting 4	
plasmids. SD-WLHA medium (SD minimal medium lacking Trp, Leu, His, and Ade) was 5	
used for auxotrophic selection of bait and prey protein interactions. The positive interaction 6	
was determined by growth on SD-WLHA medium at 30 oC for at least 2 days. The positive 7	
control (+) showing interactions of SV40 large T-antigen and murine p53 and negative 8	
control (vector) are indicated. (B) P. aeruginosa H1-T6SS secretion analysis. Western blot 9	
analysis of total (T) or secreted (S) proteins isolated from P. aeruginosa PAK∆retS 10	
(H1-T6SS-induced) harboring the vector pRL662 (V) or PAK∆retS harboring various 11	
overexpressed plasmids grown in tryptone soy broth (TSB) with specific antibodies. The 12	
non-secreted RNA polymerase β subunit (RNAP) was an internal control.	 The proteins 13	
analyzed and molecular weight standards are on the left and right, respectively, and with an 14	
arrowhead when necessary. (C) P. aeruginosa H1-T6SS–mediated antibacterial assay against 15	
E. coli. Overnight cultures of P. aeruginosa PAK∆retS or PAK∆retS∆tssB1 (T6SS-defective 16	
strain) harboring the vector pRL662 (V) or various tagF-Strep overexpressing plasmids were 17	
mixed with equivalent numbers of E. coli DH5α carrying a plasmid (pCR2.1) expressing 18	
β-galactosidase. Data are mean ± standard deviation (SD) of at least 3 biological replicates. 19	
Different letters above the bar indicate statistically different groups of strains (P <0.05) based 20	
on CFUs of the surviving target cells. (D)	Presence of Fha1Pa increases the stability of TagFPa 21	
protein in P. aeruginosa. Western blot analysis of total (T) proteins isolated from P. 22	
aeruginosa PAK∆retS (H1-T6SS-induced) or PAK∆retS∆H1 (deletion of retS and H1-T6SS 23	
cluster) harboring various plasmid combinations grown in TSB with specific antibodies. All 24	
protein samples were analyzed by SDS-PAGE followed by Coomassie blue staining (CBR) 25	
	 34	
and served as an internal control. The proteins analyzed and molecular weight standards are 1	
on the left and right, respectively, and with arrowheads when necessary. 2	
Figure 9 Proposed models of TPP activation and TagF-mediated post-translational 3	
repression of type VI secretion in A. tumefaciens and P. aeruginosa.  4	
Proposed models of TPP activation (T6SS ON) and TagF-mediated repression (T6SS OFF) in 5	
A. tumefaciens (upper panel) and P. aeruginosa (lower) are illustrated. Key activation or 6	
repression events are summarized at the bottom of each model. Protein names are indicated in 7	
or near the designated molecules. IM: inner membrane, OM: outer membrane. Detailed 8	
description of proposed models is in the text. 9	
Supporting Information Legends 10	
Information S1 11	
  12	
Figure S1 Type VI secretion assay in ΔtssL harboring two plasmids. Western blot analysis 13	
of secreted (S) (A) and total (T) (B) proteins isolated from ΔtssL (pTssL-His) harboring the 14	
vector pTrc200 (V) or tagF-pppA–overexpressing plasmid (pTrc-TagF-PppA) or tagF–15	
overexpressing plasmid (pTrc-TagF) or tagF-Strep–overexpressing plasmid (pTrc-TagF-Strep) 16	
or pppA–overexpressing plasmid (pTrc-PppA) grown in AB-MES (pH 5.5) liquid culture with 17	
specific antibodies. The non-secreted protein ActC and RNA polymerase α subunit RpoA 18	
were internal controls. The proteins analyzed and molecular weight standards are on the left 19	
and right, respectively, and indicated with an arrowhead when necessary. FL, full-length 20	
TagF-PppA proteins. 21	
Figure S2 Yeast two-hybrid protein–protein interaction studies. Yeast two-hybrid 22	
protein–protein interaction results with (A) P. aeruginosa TagF (TagFPa) and Fha1 (Fha1Pa) 23	
	 35	
proteins and (B) A. tumefaciens TagF proteins. SD-WL medium (SD minimal medium 1	
lacking Trp and Leu) was used for selecting plasmids. SD-WLHA medium (SD minimal 2	
medium lacking Trp, Leu, His, and Ade) was used for auxotrophic selection of bait and prey 3	
protein interactions. The positive interaction was determined by growth on SD-WLHA 4	
medium at 30 oC for at least 2 days. The positive control (+) showing interactions of SV40 5	
large T-antigen and murine p53 and negative control (vector) are indicated. 6	
Figure S3 Amino acid sequence alignment of TagF orthologs, and western blot analysis 7	
of total proteins from yeast with various plasmid combinations. (A) Amino acid sequence 8	
alignment of the TagF or TagF domain orthologs from A. tumefaciens (TagF-PppA/Atu4331, 9	
accession: NP_356324.2), P. aeruginosa (TagF/PA0076,	 accession: NP_248766.1), 10	
Nitrococcus mobilis (NB231_12224, accession: ZP_01126757.1), Burkholderia thailandensis 11	
(Hypothetical protein BTH_I2955, accession: YP_443462.1), and Pseudomonas syringae 12	
(Hypothetical protein PSPPH_0124, accession:	 YP_272434.1). Conserved amino acid 13	
residues are highlighted in black and marked below, and G22, K23, D44, W46, S93, D95, 14	
R99, F141 and D142 used for mutagenesis are indicated with an asterisk. The relative 15	
positions of these conserved amino acid residues in P. aeruginosa TagFPa are respectively 16	
indicated in parentheses. The residues required for dimer formation in P. aeruginosa TagF 17	
(V105, L169, L172, A173, and L195 in TagFPa) (34) are indicated with a down arrow. 18	
Sequences were aligned and highlighted by use of ClustalW2 19	
(http://www.ebi.ac.uk/Tools/msa/clustalw2/). Part of the aligned result is shown in Figure 6A. 20	
(B) According to Figure 6D. Western blot analysis of total (T) proteins isolated from yeast 21	
with various plasmid combinations with specific antibodies. The AD vector expressing SV40 22	
large T-antigen (T) or A. tumefaciens Fha proteins tagged with HA, and BD vector expressing 23	
murine p53 (53) or various A. tumefaciens TagF (TagF, TagFGK, TagFDF, TagFDW, TagFSDR, 24	
and TagFFD) proteins tagged with Myc. (C) According to Figure 8A. Western blot analysis of 25	
	 36	
total (T) proteins isolated from yeast with various plasmid combinations with specific 1	
antibodies. The AD vector expressing SV40 large T-antigen (T) or P. aeruginosa Fha1 2	
(Fha1Pa) proteins tagged with HA, and BD vector–expressing murine p53 (53) or various P. 3	
aeruginosa TagF (TagFPa, TagFPa-GK, and TagFPa-SDR) proteins tagged with Myc. All protein 4	
samples were analyzed by SDS-PAGE followed by Coomassie blue staining (CBR) and 5	
served as an internal control. The proteins analyzed and molecular weight standards are on the 6	
left and right, respectively, and indicated with an arrowhead when necessary. 7	
Figure S4 Type VI secretion analysis. Western blot analysis of total (T) and secreted (S) 8	
proteins isolated from wild-type C58, ∆tssL, ∆tagF-pppA, or chromosomally encoded 9	
tagF-pppA variants, including tagF-pppA with substitutions of tagF domain (tagFGK-pppA, 10	
tagFDW-pppA, and tagFSDR-pppA) grown in AB-MES (pH 5.5) liquid culture with specific 11	
antibodies. The non-secreted protein ActC and RNA polymerase α subunit RpoA were 12	
internal controls.	The proteins analyzed and sizes of molecular weight standards are on the 13	
left and right, respectively, and with arrow when necessary. 14	
 15	
Table S1. Bacterial strains and plasmids. 16	
Table S2. Primer information. 17	
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Supporting Information Legends 2 
 3 
Information S1 4 
The growth conditions. A. tumefaciens was grown at 25 °C in 523 (1), whereas LB (2) were 5 
routinely used for E. coli and P. aeruginosa strains at 37 °C unless indicated. The plasmids 6 
were maintained by the addition of 50 µg/mL gentamycin (Gm) and 200 µg/mL 7 
spectinomycin (Sp) for A. tumefaciens and 100 µg/mL ampicillin (Ap), 100 µg/mL 8 
spectinomycin (Sp), 20 µg/mL kanamycin (Km), and 50 µg/mL Gm for E. coli, and 50 µg/mL 9 
Gm, and 2000 µg/mL Sp for P. aeruginosa. Growth conditions are as previously described 10 
(3,4). 11 
Plasmid construction and generation of in-frame deletion mutants. Plasmid 12 
pJQ200KS-ΔppkAΔtagF-pppA (Supplementary Table S1) was created by ligating the 13 
XbaI/BamHI-digested PCR product 1 (~500 bp DNA fragment upstream of tagF-pppA gene) 14 
and the BamHI/XmaI-digested PCR product 2 (~500 bp DNA fragment downstream of ppkA 15 
gene) into XbaI/XmaI sites of pJQ200KS (5) and used to generate the ppkA and tagF-pppA 16 
genes deletion mutant (Supplementary Tables S1 and S2). The resulting strain was confirmed 17 
by PCR and designated as EML4307 (ΔppkAΔtagF-pppA). 18 
To construct the plasmids for expressing proteins in A. tumefaciens, each DNA fragment 19 
containing the ribosomal-binding sequence (RBS) and ORF (with stop codon) of tagF-pppA, 20 
tagF, tagF-Strep, tagFGK-Strep, tagFDF-Strep, tagFDW-Strep, tagFSDR-Strep, tagFFD-Strep, and 21 
pppA were PCR-amplified with primers described in Supplementary Table S2 and 22 
respectively cloned into pTrc200 (6) with appropriate enzyme sites to create the plasmids 23 
pTrc-TagF-PppA, pTrc-TagF, pTrc-TagF-Strep, pTrc-TagFGK-Strep, pTrc-TagFDF-Strep, 24 
pTrc-TagFDW-Strep, pTrc-TagFSDR-Strep, pTrc-TagFFD-Strep, and pTrc-PppA. 25 
To construct the plasmids for expressing proteins in P. aeruginosa, the gene of interest 26 
containing its RBS and ORF was cloned to be driven by a lac promoter on the broad host 27 
range vector pRL662 (7). The PCR products of P. aeruginosa tagF, tagF-Strep, tagFGK-Strep, 28 
and tagFSDR-Strep were amplified with primers described in Supplementary Table S2 and 29 
respectively digested by XhoI/XbaI, and cloned into the same sites of pRL662, which resulted 30 
in the plasmids pTagFPa, pTagFPa-Strep, pTagFPa-GK-Strep, and pTagFPa-SDR-Strep. The PCR 31 
product of P. aeruginosa fha1-HA was amplified with primers described in Supplementary 32 
Table S2 and cloned into pTrc200 with appropriate enzyme sites, which resulted in the 33 
plasmid pTrc-Fha1Pa-HA. 34 
To construct the plasmid for protein expression in E. coli, the DNA fragment containing 35 
tagF 1-214 was PCR-amplified with primers described in Supplementary Table S2 and cloned 36 
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 3 
into pET28a(+) to create the plasmid pET28a(+)-TagF 1-214. 1 
For the constructs used for yeast two-hybrid, the fha, tagF-pppA, tagF, tagFGK, tagFDF, 2 
tagFDW, tagFSDR, tagFFD, tagFPa, tagFPa-GK, tagFPa-SDR ,and fha1Pa ORFs (without stop codon) 3 
were PCR-amplified with primers described in Supplementary Table S2 and respectively 4 
cloned into pGBKT7 or pGADT7 with appropriate enzyme sites to create the plasmids 5 
pGBKT7-TagF-PppA, pGBKT7-TagF, pGBKT7-TagFGK, pGBKT7-TagFDF, 6 
pGBKT7-TagFDW, pGBKT7-TagFSDR, pGBKT7-TagFFD, pGBKT7-TagFPa, 7 
pGBKT7-TagFPa-GK, pGBKT7-TagFPa-SDR, pGBKT7-Fha1Pa, pGADT7-Fha, pGADT7-TagF, 8 
pGADT7-TagFPa, and pGADT7-Fha1Pa, respectively. 9 
For the constructs used for bacterial two-hybrid, the tagFPa and fha1Pa ORFs (without 10 
stop codon) were PCR-amplified with primers described in Supplementary Table S2 and 11 
respectively cloned into pKT25 (8) or pUT18C (8) with appropriate enzyme sites to create the 12 
plasmids pKT25-TagFPa, pKT25-Fha1Pa, pUT18C-TagFPa, and pUT18C-Fha1Pa, respectively. 13 
 14 
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Table S1. Bacterial strains and plasmids 
Strain /plasmid Relevant characteristics Source/    
reference 
A. tumefaciens   
C58 Wild type virulent strain containing nopaline-type Ti 
plasmid pTiC58 
Eugene 
Nester 
EML1060 ppkA(atu4330) in frame deletion mutant, C58ΔppkA (1) 
EML1063 tagF-pppA (atu4331) in frame deletion mutant, 
C58ΔtagF-pppA 
(1) 
EML4307 ppkA and tagF-pppA in-frame deletion mutant, 
C58ΔppkAΔtagF-pppA 
This study 
EML1073 tssL (atu4333) in-frame deletion mutant, C58ΔtssL (2) 
EML3561 Deletion from atu3639 to atu3640, atu4350 to atu4351, and 
atu4346 to atu4347, C58Δ3TIs 
(3) 
EML4515 tagF-pppA with G22A and K23A substitutions, 
C58tagFGK-pppA 
This study 
EML4517 tagF-pppA with D44A and W46A substitutions, 
C58tagFDW-pppA 
This study 
EML4519 tagF-pppA with S93A, D95A and R99A substitutions, 
C58tagFSDR-pppA 
This study 
P. aeruginosa   
PAKΔretS In-frame deletion of retS (PA4856) in PAK (4) 
PAKΔretSΔH1 Deletion of retS and H1-T6SS cluster in PAK (5) 
PAKΔretSΔtssB1 In-frame deletion of retS and tssB1 (PA0083) in PAK (6) 
E. coli   
DH10B Host for DNA cloning Invitrogen 
DH5α Host for DNA cloning Laboratory 
collection 
BL21 (DE3) Host for overexpressing genes driven by the T7 promoter (7) 
S. cerevisiae   
AH109 Host for yeast two-hybrid analysis Clontech 
Plasmids   
pRL662 GmR, broad-host range vector derived from pBBR1MCS-2 (8) 
pJQ200KS GmR, suicide plasmid containing Gmr and sacB gene for 
selection of double crossover 
(9) 
pET28a(+) KmR, E. coli overexpression vector to produce N or 
C-terminal His-tagged protein 
Novagen 
pTrc200 SpR , pVS1 origin lacIq, trc promoter expression vector (10) 
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pCR2.1 ApR, KmR, TA cloning vector Invitrogen 
pGADT7 ApR, AD vector used in yeast two-hybrid assay Clontech 
pGBKT7 KmR, DNA-BD vector used in yeast-two hybrid assay Clontech 
pKT25 KmR, BTH vector for fusion of target proteins to B. pertussis 
cya gene T25 fragment; Plac::cya1–675 p15ori 
(11) 
pUT18C ApR, BTH vector for fusion of target proteins to B. pertussis 
cya gene T18 fragment; Plac::cya675–1197 pUCori 
(11) 
pTagFPa GmR, pRL662 expressing P. aeruginosa TagF driven by 
lacZp 
This study 
pTagFPa-Strep GmR, pRL662 expressing P. aeruginosa TagF-Strep fusion 
protein driven by lacZp 
This study 
pTagFPa-GK-Strep GmR, pRL662 expressing P. aeruginosa TagF-Strep fusion 
protein with G8A and K9A substitutions driven by lacZp 
This study 
pTagFPa-SDR-Strep GmR, pRL662 expressing P. aeruginosa TagF-Strep fusion 
protein with S79A, D81A, and R85A substitutions driven by 
lacZp 
This study 
pTssL-His GmR, pRL662 expressing TssL-His fusion protein driven by 
lacZp 
(12) 
pTrc-TagF-PppA SpR, pTrc200 expressing TagF-PppA full-length protein This study 
pTrc-TagF SpR, pTrc200 expressing TagF domain (1-230 a.a.) This study 
pTrc-TagF-Strep SpR, pTrc200 expressing TagF-Strep fusion protein This study 
pTrc-TagFGK-Strep SpR, pTrc200 expressing TagF-Strep fusion protein with 
G22A and K23A substitutions 
This study 
pTrc-TagFDF-Strep SpR, pTrc200 expressing TagF-Strep fusion protein with 
D29A and F30A substitutions 
This study 
pTrc-TagFDW-Strep SpR, pTrc200 expressing TagF-Strep fusion protein with 
D44A and W46A substitutions 
This study 
pTrc-TagFSDR-Strep SpR, pTrc200 expressing TagF-Strep fusion protein with 
S93A, D95A and R99A substitutions 
This study 
pTrc-TagFFD-Strep SpR, pTrc200 expressing TagF-Strep fusion protein with 
F141A and D142A substitutions 
This study 
pTrc-PppA SpR, pTrc200 expressing PppA domain (231-471 a.a.) This study 
pTrc-Fha1Pa-HA SpR, pTrc200 expressing P. aeruginosa Fha1-HA fusion 
protein 
This study 
pGBKT7-TagF-PppA KmR, DNA-BD vector expressing TagF-PppA This study 
pGBKT7-TagF KmR, DNA-BD vector expressing TagF domain (1-230 a.a.) This study 
pGBKT7-TagFGK KmR, DNA-BD vector expressing TagF domain (1-230 a.a.) 
with G22A and K23A substitutions 
This study 
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pGBKT7-TagFDF KmR, DNA-BD vector expressing TagF domain (1-230 a.a.) 
with D29A and F30A substitutions 
This study 
pGBKT7-TagFDW KmR, DNA-BD vector expressing TagF domain (1-230 a.a.) 
with D44A and W46A substitutions 
This study 
pGBKT7-TagFSDR KmR, DNA-BD vector expressing TagF domain (1-230 a.a.) 
with S93A, D95A and R99A substitutions 
This study 
pGBKT7-TagFFD KmR, DNA-BD vector expressing TagF domain (1-230 a.a.) 
with F141A and D142A substitutions 
This study 
pGBKT7-TagFPa KmR, DNA-BD vector expressing P. aeruginosa TagF This study 
pGBKT7-TagFPa-GK KmR, DNA-BD vector expressing P. aeruginosa TagF with 
G8A and K9A substitutions 
This study 
pGBKT7-TagFPa-SDR KmR, DNA-BD vector expressing P. aeruginosa TagF with 
S79A, D81A, and R85A substitutions 
This study 
pGBKT7-Fha1Pa KmR, DNA-BD vector expressing P. aeruginosa Fha1 This study 
pGBKT7-53 KmR, DNA-BD vector expressing murine p53  Clontech 
pGADT7-TagF APR, AD vector expressing TagF domain (1-230 a.a.) This study 
pGADT7-Fha APR, AD vector expressing Fha This study 
pGADT7-TagFPa APR, AD vector expressing P. aeruginosa TagF This study 
pGADT7-Fha1Pa APR, AD vector expressing P. aeruginosa Fha1 This study 
pGADT7-T ApR, AD vector expressing SV40 large T-antigen Clontech 
pKT25-TagFPa KmR, fusion of tagFPa to cya gene T18 fragment in pKT25 This study 
pKT25-Fha1Pa KmR, fusion of fha1Pa to cya gene T18 fragment in pKT25 This study 
pUT18C-TagFPa ApR, fusion of tagFPa to cya gene T25 fragment in pUT18C This study 
pUT18C-Fha1Pa ApR, fusion of fha1Pa to cya gene T25 fragment in pUT18C This study 
pJQ200KS-ΔppkAΔtagF-p
ppA 
GmR, used in generating ppkA and tagF-pppA double 
deletion mutant of A. tumefaciens C58 
This study 
pJQ200KS- tagFGK-pppA GmR, used in generating tagF-pppA with G22A and K23A 
substitutions of A. tumefaciens C58 
This study 
pJQ200KS- tagFDW-pppA GmR, used in generating tagF-pppA with D44A and W46A 
substitutions of A. tumefaciens C58 
This study 
pJQ200KS- tagFSDR-pppA GmR, used in generating tagF-pppA with S93A, D95A, and 
R99A substitutions of A. tumefaciens C58 
This study 
pET28a(+)-tagF 1-214 KmR, pET28a(+) expressing N-terminal His-tagged TagF 
1-214 aa protein 
This study  
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Table S2. Primer information 
Primer Plasmids Sequence (5 '-3')a Source / 
reference 
TagF-PppA F-BamHI pTrc-TagF 5'-CGGGATCCTTATGATGAAGGCAAGCA
CG-3' 
(1) 
TagF N1-230 R-XbaI 5'-GCTCTAGACTATGTCTTCTCCTGCACC
GTTGC-3' 
This study 
TagF-PppA F-BamHI pTrc-TagF-Strep 5'-CGGGATCCTTATGATGAAGGCAAGCA
CG-3' 
(1) 
TagF N1-230-Strep 
R-XbaI 
5'-GCTCTAGACTACTTTTCGAACTGCGG
GTGGCTCCATGTCTTCTCCTGCACCGTT
GC-3' 
This study 
TagF-PppA F-BamHI pTrc-TagFGK-Strep 5'-CGGGATCCTTATGATGAAGGCAAGCA
CG-3' 
(1) 
TagF N1-230-Strep 
R-XbaI 
5'-GCTCTAGACTACTTTTCGAACTGCGG
GTGGCTCCATGTCTTCTCCTGCACCGTT
GC-3' 
This study 
TagF GK-1 5'-CCATGGCTGGGGACCGCGGCGAAGA
AACCGATGC-3' 
This study 
TagF GK-2 5'-GCATCGGTTTCTTCGCCGCGGTCCCC
AGCCATGG-3' 
This study 
TagF-PppA F-BamHI pTrc-TagFDF-Strep 5'-CGGGATCCTTATGATGAAGGCAAGCA
CG-3' 
(1) 
TagF N1-230-Strep 
R-XbaI  
5'-GCTCTAGACTACTTTTCGAACTGCGG
GTGGCTCCATGTCTTCTCCTGCACCGTT
GC-3' 
This study 
TagF DF-1 5'-GAGCCCATCGGAAATGGCAGCGCCA
TGGCTGGGGAC-3' 
This study 
TagF DF-2 5'-GTCCCCAGCCATGGCGCTGCCATTTC
CGATGGGCTC-3' 
This study 
TagF-PppA F-BamHI pTrc-TagFDW-Strep 5'-CGGGATCCTTATGATGAAGGCAAGCA
CG-3' 
(1) 
TagF N1-230-Strep 
R-XbaI 
5'-GCTCTAGACTACTTTTCGAACTGCGG
GTGGCTCCATGTCTTCTCCTGCACCGTT
GC-3' 
This study 
TagF DW-1 5'-CATGCCGGATCGCATCGCGTCGGCGA
AGGTAGCGATCA-3' 
This study 
TagF DW-2 5'-TGATCGCTACCTTCGCCGACGCGATG
CGATCCGGCATG-3' 
This study 
TagF-PppA F-BamHI pTrc-TagFSDR-Strep 5'-CGGGATCCTTATGATGAAGGCAAGCA
CG-3' 
(1) 
TagF N1-230-Strep 
R-XbaI 
5'-GCTCTAGACTACTTTTCGAACTGCGG
GTGGCTCCATGTCTTCTCCTGCACCGTT
GC-3' 
This study 
TagF SDR-1 5'-GGATATTTAGCGCCCACCCGGGCGG
CGGCCGGCACCAGCACG-3' 
This study 
TagF SDR-2 5'-CGTGCTGGTGCCGGCCGCCGCCCGG
GTGGGCGCTAAATATCC-3' 
This study 
TagF-PppA F-BamHI pTrc-TagFFD-Strep 5'-CGGGATCCTTATGATGAAGGCAAGCA
CG-3' 
(1) 
TagF N1-230-Strep 
R-XbaI 
5'-GCTCTAGACTACTTTTCGAACTGCGG
GTGGCTCCATGTCTTCTCCTGCACCGTT
GC-3' 
This study 
TagF FD-1 5'-CATTAAACCGGGACACGGCGGCATC
GCCGGTCATCGAT-3' 
This study 
TagF FD-2 5'-ATCGATGACCGGCGATGCCGCCGTGT
CCCGGTTTAATG-3' 
This study 
TagFPa F-XhoI pTagFPa 5'-CCGCTCGAGCCAGCATCGCCTGCGAG
CTGC-3' 
This study 
TagFPa R-XbaI 5'-GCTCTAGACGACCTGTAGTAGCTGAC
TGAG-3' 
This study 
TagFPa F-XhoI pTagFPa-Strep 5'-CCGCTCGAGCCAGCATCGCCTGCGAG
CTGC-3' 
This study 
TagFPa Strep R-XbaI 5'-GCTCTAGACTACTTTTCGAACTGCGG
GTGGCTCCAACCGGGTATGCCGGGAAA
GAGC-3' 
This study 
TagFPa F-XhoI pTagFPa-GK-Strep 5'-CCGCTCGAGCCAGCATCGCCTGCGAG
CTGC-3' 
This study 
TagFPa Strep R-XbaI 5'-GCTCTAGACTACTTTTCGAACTGCGG
GTGGCTCCAACCGGGTATGCCGGGAAA
GAGC-3' 
This study 
TagFPa GK-1 5'-CCGCGGCCGGCCAGCGCGGCGTAGA
AACCGACGC-3' 
This study 
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TagFPa GK-2 5'-GCGTCGGTTTCTACGCCGCGCTGGCC
GGCCGCGG-3' 
This study 
TagFPa F-XhoI pTagFPa-SDR-Strep 5'-CCGCTCGAGCCAGCATCGCCTGCGAG
CTGC-3' 
This study 
TagFPa Strep R-XbaI 5'-GCTCTAGACTACTTTTCGAACTGCGG
GTGGCTCCAACCGGGTATGCCGGGAAA
GAGC-3' 
This study 
TagFPa SDR-1 5'-GGGAAATAGGCACCGACCCGGGCGA
TGGCCGGCATCACCACT-3' 
This study 
TagFPa SDR-2 5'-AGTGGTGATGCCGGCCATCGCCCGG
GTCGGTGCCTATTTCCC-3' 
This study 
PppA 
C231-471-BamHI 
pTrc-PppA 5'-CGGGATCCATGAAACAGCAAATACC
GCCCGTG-3' 
This study 
TagF-PppA R-XbaI 5'-GCTCTAGAGGATAGGCAGGCTCATCA
AG-3' 
(1) 
TagF-PppA F-BamHI pTrc-TagF-PppA 5'-CGGGATCCTTATGATGAAGGCAAGCA
CG-3' 
(1) 
TagF-PppA R-XbaI 5'-GCTCTAGAGGATAGGCAGGCTCATCA
AG-3' 
(1) 
Fha1Pa F-NcoI pTrc-Fha1Pa-HA 5'-CATGCCATGGCCTGGATGCGAACCGA
AATCC-3' 
This study 
Fha1Pa HA R-XbaI 5'-GCTCTAGATCAAGCGTAATCTGGAAC
ATCGTATGGGTAGGAACGCCGTAGTCG
AGCGCTG-3' 
This study 
TagF-PppA F pGBKT7-TagF-PppA 5'-TGGCCGATCAGGCATCAAGG-3' (2) 
TagF-PppA R-BamHI 5'-CGGGATCCGCCTTGCTCACGCCGGTT
TC-3' 
This study 
TagF-PppA F 1. pGBKT7-TagF 
2. pGBKT7-TagFGK 
(pTrc-TagFGK-Strep as template) 
3. pGBKT7-TagFDF 
(pTrc-TagFDF-Strep as template) 
4. pGBKT7-TagFDW 
(pTrc-TagFDW-Strep as template) 
5. pGBKT7-TagFSDR 
(pTrc-TagFSDR-Strep as template) 
6. pGBKT7-TagFFD 
(pTrc-TagFFD-Strep as template) 
7. pGADT7-TagF 
5'-TGGCCGATCAGGCATCAAGG-3' (2) 
TagF R-BamHI 5'-CGGGATCCTGTCTTCTCCTGCACCGTT
GC-3' 
This study 
Fha F-NdeI pGADT7-Fha 5'-GAACATATGAAGCTTGCACTCAAGAA
CAC-3' 
(2) 
Fha R-BamHI 5'-CGGGATCCTGTCTCATCGTGGTTGTTT
ACC-3' 
This study 
TagFPa F 1. pGBKT7-TagFPa 
2. pGBKT7-TagFPa-GK 
(pTrc-TagFPa-GK-Strep as template) 
3. pGBKT7-TagFPa-SDR 
(pTrc-TagFPa-SDR-Strep as template) 
4. pGADT7-TagFPa 
5'-TGTTGAACAGCGTCGGTTTCTACG-3' This study 
TagFPa R-BamHI 5'-CGGGATCCACCGGGTATGCCGGGAA
AGAGC-3' 
This study 
Fha1Pa F 1. pGBKT7-Fha1Pa 
2. pGADT7-Fha1Pa 
5'-TGCCGCTGCGATTGACCATCAC-3' This study 
Fha1Pa R-BamHI 5'-CGGGATCCGGAACGCCGTAGTCGAGC
GCTG-3' 
This study 
TagFPa F-XbaI 1. pKT25-TagFPa 
2. pUT18C-TagFPa 
5'-GCGCGTCTAGAGTTGAACAGCGTCGG
TTTCTACG-3' 
This study 
TagFPa R-EcoRI 5'-GCGCGGAATTCTTAACCGGGTATGCC
GGGA-3' 
This study 
Fha1Pa F-XbaI 1. pKT25-Fha1Pa 
2. pUT18C-Fha1Pa 
5'-GTTAGTCTAGAGATGCCGCTGCGATT
GACCAT-3' 
This study 
Fha1Pa R-BamHI 5'-AATACGGATCCTCAGGAACGCCGTAG
TCGAG-3' 
This study 
PpkA 2F-BamHI pJQ200KS-ΔppkAΔtagF-pppA 5'-CGGGATCCCTGTAGCGCCGGCGTCAG
TTG-3' 
(2) 
PpkA 2R-XmaI 5'-TCCCCCCGGGCCCGTCAGGAGCGTGT
ACTTG-3' 
(2) 
TagF-PppA 1F-XbaI 5'-GCTCTAGAGCCCAGTTCGAAAATGCC
GAC-3' 
(2) 
TagF-PppA 
1R-BamHI 
5'-CGGGATCCATCGGCCATCAGTTGCGA
TTG-3' 
(2) 
TagF-PppA 1F-XbaI pJQ200KS-tagFGK-pppA 5'-GCTCTAGAGCCCAGTTCGAAAATGCC
GAC-3' 
(2) 
TagF-PppA 2R-XmaI 5'-TCCCCCCGGGCGAAGGATCGAGATCA
CCTGC-3' 
(2) 
TagF GK-1 5'-CCATGGCTGGGGACCGCGGCGAAGA
AACCGATGC-3' 
This study 
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TagF GK-2 5'-GCATCGGTTTCTTCGCCGCGGTCCCC
AGCCATGG-3' 
This study 
TagF-PppA 1R 5'-GATCGATGTGCCACCAGAGG-3' This study 
TagF-PppA 1F-XbaI pJQ200KS-tagFDW-pppA 5'-GCTCTAGAGCCCAGTTCGAAAATGCC
GAC-3' 
(2) 
TagF-PppA 2R-XmaI 5'-TCCCCCCGGGCGAAGGATCGAGATCA
CCTGC-3' 
(2) 
TagF DW-1 5'-GAGCCCATCGGAAATGGCAGCGCCA
TGGCTGGGGAC-3' 
This study 
TagF DW-2 5'-GTCCCCAGCCATGGCGCTGCCATTTC
CGATGGGCTC-3' 
This study 
TagF-PppA 1R 5'-GATCGATGTGCCACCAGAGG-3' This study 
TagF-PppA 1F-XbaI pJQ200KS-tagFSDR-pppA 5'-GCTCTAGAGCCCAGTTCGAAAATGCC
GAC-3' 
(2) 
TagF-PppA 2R-XmaI 5'-TCCCCCCGGGCGAAGGATCGAGATCA
CCTGC-3' 
(2) 
TagF SDR-1 5'-GGATATTTAGCGCCCACCCGGGCGG
CGGCCGGCACCAGCACG-3' 
This study 
TagF SDR-2 5'-CGTGCTGGTGCCGGCCGCCGCCCGG
GTGGGCGCTAAATATCC-3' 
This study 
TagF-PppA 1R 5'-GATCGATGTGCCACCAGAGG-3' This study 
TagF 1-214 F pET28a(+)-tagF 1-214 5'-CAGGCAAAGGCGACGAGTAACAAAG
CCCGAAAG-3' 
This study 
TagF 1-214 R  5'-CTTTCGGGCTTTGTTACTCGTCGCCTT
TGCCTG-3' 
This study 
a: Restriction enzyme sites are underlined, and mutated sequences are indicated by 
bold type. 
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